Navigation Links
Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
Date:4/26/2012

results of the second trial are pending, the current intention is not to pursue a regulatory filing for this indication for MMX mesalamine.

Lisdexamfetamine dimesylate ("LDX") (currently marketed as VYVANSE in the US for the treatment of ADHD) for the treatment of Binge Eating Disorder ("BED")

  • Today, Shire announced Phase 2 results from an efficacy and safety clinical study of LDX for the treatment of BED. In this study, in which the pre-defined primary end point was met, treatment of adults with LDX resulted in a statistically significant reduction in binge eating behaviour and increased remission rates from binge eating compared to placebo. There is currently no approved pharmacologic treatment for patients struggling with BED, the most common eating disorder.

FIRST QUARTER AND RECENT BUSINESS DEVELOPMENT ACTIVITY

Since the beginning of the year we have added to our pipeline through the following transactions:


Acquisition of FerroKin Biosciences, Inc. ("FerroKin")

  • On April 2, 2012 Shire completed the acquisition of FerroKin and with it SPD 602 (formally referred to as FBS0701), FerroKin's iron chelator treatment in Phase 2 development. SPD 602 serves a chronic patient need for treatment of iron overload following numerous blood transfusions. Together with our collaboration with Sangamo Biosciences Inc. ("Sangamo"), the acquisition of FerroKin represents a strategic step in building Shire's hematology business, which already includes XAGRID® and a growing development pipeline, including SPD 535. Cash consideration paid on closing amounted to $94.5 million. Further contingent cash consideration of up to $225 million may be payable by Shire in future periods, dependent upon the achievement of certain clinical development, regulatory and net sales milestones.

Acquisition of certain assets
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... FREDERICK, Md. , May 23, 2013  BioElectronics ... safe consumer medical devices, comments on the FDA panel ... Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting ... Gaithersburg, MD , USA.  The focus of the ... instructed the panel to focus solely on the application ...
(Date:5/23/2013)... , May 23, 2013 Halozyme ... announced the appointment of David A. ... Ramsay was most recently Vice President, Corporate Development ... )     "With his established financial management ... gained by working in our commercial group for ...
(Date:5/23/2013)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ), the ... a company overview at the Deutsche Bank 38 th ... at 8:40 a.m. ET in Boston, MA. ... will be available on the "Investors & Media" section of ... be available on the Isis Web site within 48 hours ...
Breaking Medicine Technology:BioElectronics and Pulsed Shortwave Therapy Make Progress 2Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2
... Care Doctors, Endocrinologists Feel Ill-Equipped to Provide Ideal, Multi-Disciplinary Team ... of doctors surveyed said they did not have enough time ... to their patients with diabetes, according to the results of ... in American Health & Drug Benefits . , An ...
... 19 WaferGen Biosystems, Inc. (OTC Bulletin Board: ... systems, today announced a new, innovative service for ... SmartChip(TM) Real-Time PCR System. By taking advantage ... offer universities, pharmaceutical and diagnostic companies a service ...
Cached Medicine Technology:Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show 2Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show 3Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show 4Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show 5WaferGen to Introduce New Service for Gene-Expression Profiling Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Introduce New Service for Gene-Expression Profiling Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Introduce New Service for Gene-Expression Profiling Using the SmartChip(TM) Real-Time PCR System 4
(Date:5/23/2013)... (PRWEB) May 23, 2013 Kantar ... announced the availability of CancerMPact® Biomarker Analysis , ... current and evolving oncology landscape. The analysis ... recently published data covering the following biomarkers: , *BRAF ... cell lung cancer) , *KRAS (colorectal cancer) , *TNBC ...
(Date:5/23/2013)... May 23, 2013 Sharon Kleyne and ... a new product to supplement natural tear film water ... The product, Nature’s Tears® EyeMist®, according to Kleyne, is ... a 100% fresh water mist to the air around ... Kleyne, who describes herself as “educator, inventor, radio commentator ...
(Date:5/23/2013)... 23, 2013 With crowded gyms, bodyweight ... But according to Mike Whitfield, a bodyweight expert in ... like the medicine ball can add a whole new ... BodyweightTorch.com, a website in which anyone can download a ... equipment. Recently, he shared a video with his subscribers ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Studies show that ... times per week are less likely to be overweight, less ... perform better academically, and have better relationships with their parents. ... in danger, according to family dinner expert and advocate ... have declined by 33 percent. When families do eat together, ...
(Date:5/23/2013)... CA (PRWEB) May 23, 2013 ... that their condition specific remedies are now available at ... Laguna Niguel, CA 92677. The line of natural biotherapy ... Foods Market Chain. , Represented by Brandstorm HBC (Los ... Whole Foods Markets throughout California, Nevada and Arizona, as ...
Breaking Medicine News(10 mins):Health News:Kantar Health Launches CancerMPact Biomarker Analysis 2Health News:Water Entrepreneur Announces First Ever Personal Dry Eye Humidifier 2Health News:Unique Ab Exercise, the Medicine Ball Chop, Released from BodyweightTorch.com 2Health News:Family Dinner Expert and Cookbook Author Announces “Family Dinner Challenge” 2Health News:Dr. Garber's Natural Solutions Now Available at Whole Foods Market, Laguna Niguel, CA 2
... ... The award will be used learn how African health care providers are collaborating with ... acute medical care in Africa. , ... Baltimore, Maryland (PRWEB) September 8, 2009 -- The recent tragic death ...
... , ... healing testimonial for ColorAlchemy by licensed Marriage and Family Therapist and Clinical Hypnotherapist David Swindoll ... ... Family Therapist and Clinical Hypnotherapist for over thirty years. He has found the use of ...
... efforts focused on the community pay off, study finds ... and delinquent behavior among teens was significantly reduced in ... study found. , The Communities That Care prevention system, ... seven states, slashed alcohol use by eighth graders by ...
... HEIDELBERG, Germany, September 7 SYGNIS Pharma,AG (Frankfurt: ... present at the 11th Rodman & Renshaw Annual Global,Investment Conference, ... The presentation will be given by Prof. Karoly Nikolich, CEO ... 2:25 p.m. EDT (20:25,CET) in the Garrison Salon. , ...
... LONDON, September 7 Bounty, the UK,s favourite parenting,club, today ... help,expectant and new mums take a real life, close up peek ... To view the Multimedia News Release, please ... Breastfeeding is the healthiest and most natural way ...
... Institutes of Health Research (CIHR) has announced a grant totaling ... on Alzheimer,s disease. MacDonald is the Director of the ... "If you have a stroke and survive, you have a ... These diseases are already taking a huge toll on ...
Cached Medicine News:Health News:Medical Student Wins Travel Scholarship to Kenya to Study Operative Care in Africa 2Health News:Medical Student Wins Travel Scholarship to Kenya to Study Operative Care in Africa 3Health News:Licensed Marriage and Family Therapist and Clinical Hypnotherapist Provides Powerful Video Testimony for ColorAlchemy and Color Therapy 2Health News:Licensed Marriage and Family Therapist and Clinical Hypnotherapist Provides Powerful Video Testimony for ColorAlchemy and Color Therapy 3Health News:Program Curbs Teen Substance Abuse, Delinquency 2Health News:SYGNIS to Present at the 11th Rodman & Renshaw Annual Global Investment Conference 2Health News:Bounty Parenting Club Launches View on Demand 'How to Breastfeed' Video 2Health News:Million dollar boost to Alzheimer's and stroke research at Robarts 2
7 mm strong curved blade. Round handle....
3 mm diameter roller blade in line with handle. Curved shaft. Flat handle. 15 mm from curve to tip....
5 mm diameter blade. Angled 45 degrees. Hexagonal handle....
0.5 mm wide x 1.5 mm long. Angled 20 degrees. Octagonal handle....
Medicine Products: